Molecular Dissection of Meis1 Reveals 2 Domains Required for Leukemia Induction and a Key Role for Hoxa Gene Activation
Overview
Authors
Affiliations
The Hoxa9 and Meis1 genes represent important oncogenic collaborators activated in a significant proportion of human leukemias with genetic alterations in the MLL gene. In this study, we show that the transforming property of Meis1 is modulated by 3 conserved domains, namely the Pbx interaction motif (PIM), the homeodomain, and the C-terminal region recently described to possess transactivating properties. Meis1 and Pbx1 interaction domain-swapping mutants are dysfunctional separately, but restore the full oncogenic activity of Meis1 when cotransduced in primary cells engineered to overexpress Hoxa9, thus implying a modular nature for PIM in Meis1-accelerated transformation. Moreover, we show that the transactivating domain of VP16 can restore, and even enhance, the oncogenic potential of the Meis1 mutant lacking the C-terminal 49 amino acids. In contrast to Meis1, the fusion VP16-Meis1 is spontaneously oncogenic, and all leukemias harbor genetic activation of endogenous Hoxa9 and/or Hoxa7, suggesting that Hoxa gene activation represents a key event required for the oncogenic activity of VP16-Meis1.
Ubiquitous MEIS transcription factors actuate lineage-specific transcription to establish cell fate.
Darieva Z, Zarrineh P, Phillips N, Mallen J, Garcia Mora A, Donaldson I EMBO J. 2025; .
PMID: 40021842 DOI: 10.1038/s44318-025-00385-5.
Nagel S, Meyer C Int J Mol Sci. 2022; 23(19).
PMID: 36233173 PMC: 9570312. DOI: 10.3390/ijms231911874.
MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy.
Blasi F, Bruckmann C J Dev Biol. 2021; 9(4).
PMID: 34698191 PMC: 8544432. DOI: 10.3390/jdb9040044.
MEIS1 and its potential as a cancer therapeutic target (Review).
Yao M, Gu Y, Yang Z, Zhong K, Chen Z Int J Mol Med. 2021; 48(3).
PMID: 34318904 PMC: 8354308. DOI: 10.3892/ijmm.2021.5014.
Bruckmann C, Tamburri S, De Lorenzi V, Doti N, Monti A, Mathiasen L Sci Rep. 2020; 10(1):16809.
PMID: 33033354 PMC: 7545097. DOI: 10.1038/s41598-020-74032-w.